It has actually ended up being an important force in the international market. The worry is that the marketplace is in a state of disorder and it needs to enhance the safety and competitive advantage.
In 2010, made up by the four major classifications of dietary supplements, natural organic food, natural care products and practical foods make up an international nutrition market size has to do with f $ 210.4 billion. It is expected that in the next 10 years the yearly growth rate will go beyond 8%; the worldwide plant extracts material with yearly sales of $ 6.5 billion, the development rate of about 20% higher than the drugs.
The very first major exporter of Chinese plant extracts is the United States accounting for exports of 30.06%. The 21.82% are exported to Europe, 16.86% are exported to Japan. Plant extracts benefit of China’s huge plant resources and fairly low operating expense. Increase of the general pattern of global aging and the natural demand for drugs will continue to supply a huge market area, which offers advancement opportunities for China’s plant extracts. Plant extracts originate from agricultural items, development of the market will be able to drive a brand-new kind of rural development.
At the same time, the plant extract industry should be standardized. First, Chinese plant extracts the current level of competitors is reasonably low, uncoordinated with the export volume of the marketplace continued to increase. Company size is relatively small, normally 2 billion to 3 billion in sales; low level of cost competitors in between enterprises, regardless of the existing exports are increasing, but earnings margins have been falling. Second, the plant extracts in the department in charge of requirements, the legal status of the 3 noes state. No standards and no legal status, making the market the limit is extremely low, leading to an increase of a large number of little irinotecan companies, and likewise planted a concealed risk for the safety of items. Third, the technological material of export varieties is fairly low and the trademarked item is not abundant. Most crude exports are reasonably low-end. The Chinese plant extracts do not have of international competitiveness primarily due to plant resource restrictions, backward extraction process, the lower the level of equipment, as well as brand-new R & & D financial investment less.
Enterprises ought to improve the technological material of products to raise earnings margins. Plant extracts are still fairly small scale and lack of benchmark business with high exposure. Chinese enterprises can select the way of the development of a complete commercial chain to construct growth companies, plant extracts is the main raw product for health products. Chinese enterprises can replicate the API producer to do the preparations the production of health products.
Plant extracts has fast development in the irregulatory environment. Chinese business usually knowledgeable about the urgency of the market norms and self-control. The country began to pay more attention to the development of this chia seed market. For medicine extract’s foreign market need, China should focus on assistance demand, high tech and extensive utilization-oriented. They can promote the specialization of Chinese medicine industry with independent intellectual residential or commercial property rights and market competitiveness of Chinese medication standard extract market, the formation of the extract of 20 type of standard Chinese medicine has a competitive benefit in the market requirement
< img src ="https://net711.win/wp-content/uploads/2021/01/jsHVXq.gif" alt ="Post Search" border ="0"/ >, the new Chinese medication basic extract exports worth $ 200 million. The sales are 2 billion RMB in China.Source: http://www.cospcn.com-Plant Based Diet